Associated Papers
Role of Genetic Thrombophilia Markers in Thrombosis Events in Elderly Patients with COVID-19.
Fevraleva I et al.
Genes, 2023
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology.
Chia YC et al.
Diagnostics (basel, Switzerland), 2023
Genetic Analysis of a Pedigree With Antithrombin and Prothrombin Compound Mutations and Antithrombin Heterozygotes.
Zhang H et al.
Frontiers in Genetics, 2022
Case report: Two unique nonsense mutations in HTRA1-related cerebral small vessel disease in a Chinese population and literature review.
Chen W et al.
Frontiers in Neurology, 2022
Association between intelectin-1 variation and human kidney stone disease in northeastern Thai population.
Pungsrinont T et al.
Urolithiasis, 2021
Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients.
Hirata TDC et al.
Molecular Diagnosis & Therapy, 2021
Prothrombotic variants as modifiers of clinical phenotype in four related individuals with haemophilia A.
Carrel L et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia, 2021
A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene.
Mansory EM et al.
Research and Practice in Thrombosis and Haemostasis, 2021
The genetics of venous thromboembolism: a systematic review of thrombophilia families.
Zhang Y et al.
Journal of Thrombosis and Thrombolysis, 2021
Identification of the Novel Variants in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Yaoita N et al.
Journal of the American Heart Association, 2020
Antiphospholipid syndrome's genetic and epigenetic aspects.
Iuliano A et al.
Autoimmunity Reviews, 2019
Correlation between genotypes of F2 rs5896 (p.Thr165Met) polymorphism and urinary prothrombin fragment 1.
Rungroj N et al.
Urolithiasis, 2018
A genetic risk factor for thrombophilia in a Han Chinese family.
Sun G et al.
Molecular Medicine Reports, 2017
Pharmacogenetics of coumarin anticoagulants in Brazilians.
Suarez-Kurtz G et al.
Expert Opinion on Drug Metabolism & Toxicology, 2015
A whole genome SNP genotyping by DNA microarray and candidate gene association study for kidney stone disease.
Rungroj N et al.
Bmc Medical Genetics, 2014
Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review.
Kulkarni BP et al.
Plos One, 2014
Association between human prothrombin variant (T165M) and kidney stone disease.
Rungroj N et al.
Plos One, 2012
Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry.
Botton MR et al.
British Journal of Clinical Pharmacology, 2011
Personalized medicine in coronary artery disease: insights from genomic research.
Lee SH et al.
Korean Circulation Journal, 2009
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
Gage BF et al.
Clinical Pharmacology and Therapeutics, 2008
Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.
D'Andrea G et al.
Blood Reviews, 2008
Polymorphisms in factor II and factor VII genes modulate oral anticoagulation with warfarin.
D'Ambrosio RL et al.
Haematologica, 2004